Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.
BACKGROUND: Chemotherapy of schistosomiasis relies on a single drug, Praziquantel (PZQ) and mass-use of this compound has led to emergence of resistant strains of Schistosoma mansoni, therefore pointing out the necessity to find alternative drugs. Through their essential functions in development and...
Saved in:
Main Authors: | Mathieu Vanderstraete (Author), Nadège Gouignard (Author), Katia Cailliau (Author), Marion Morel (Author), Julien Lancelot (Author), Jean-François Bodart (Author), Colette Dissous (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1.
by: Andreas Schubert, et al.
Published: (2014) -
Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets.
by: Julien Lancelot, et al.
Published: (2013) -
Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects.
by: Christin Buro, et al.
Published: (2014) -
Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
by: Barbara C Figueiredo, et al.
Published: (2014) -
The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction.
by: Sabine Förster, et al.
Published: (2019)